Vanta Bioscience Limited
Dopesh Mulakala is the President of India Operations at CEBIS since September 2023. Prior to this role, Dopesh has been serving as the Managing Director at Vanta Bioscience since April 2017. With a background in industrial engineering, Dopesh holds a Master of Business Administration (MBA) from the Weatherhead School of Management and has postgraduate degrees in Business Administration and Management from SPJIMR SP Jain Institute of Management & Research. Dopesh has served in various directorial and executive positions at Sarvotham Care Ltd and Sarvotham Remedies Ltd.
This person is not in any teams
This person is not in any offices
Vanta Bioscience Limited
Vanta Bioscience Limited is a leading full service pre-clinical contract research organization based on the outskirts of city of Chennai, Tamilnadu, India. Vanta Bioscience Limited is positioned to offer non clinical safety assessment services for clientele in the pharmaceutical, biotech, medical device, cosmetics, agri-foods, nutritional supplements, feed additives and chemical industries, worldwide. Complying with OECD GLP, ISO & USFDA GLP (21 CFR Part 58) regulatory guidelines, Vanta Bioscience is established as a center of excellence for GLP toxicology research.